| Drug Name | Target | ATC Codes | Indications |
|---|---|---|---|
| motexafin gadolinium | Thioredoxin reductase 1, cytoplasmic;Thioredoxin reductase 2, mitochondrial;Ribonucleoside-diphosphate reductase subunit M2 | Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's). |